17-41097597-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031960.3(KRTAP4-8):c.488C>T(p.Thr163Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000509 in 1,572,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031960.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRTAP4-8 | NM_031960.3 | c.488C>T | p.Thr163Ile | missense_variant | 1/1 | ENST00000333822.5 | NP_114166.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRTAP4-8 | ENST00000333822.5 | c.488C>T | p.Thr163Ile | missense_variant | 1/1 | 6 | NM_031960.3 | ENSP00000328444.4 |
Frequencies
GnomAD3 genomes AF: 0.000257 AC: 39AN: 151680Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.0000645 AC: 12AN: 186134Hom.: 0 AF XY: 0.0000504 AC XY: 5AN XY: 99264
GnomAD4 exome AF: 0.0000289 AC: 41AN: 1421112Hom.: 0 Cov.: 94 AF XY: 0.0000242 AC XY: 17AN XY: 702922
GnomAD4 genome AF: 0.000257 AC: 39AN: 151796Hom.: 0 Cov.: 28 AF XY: 0.000216 AC XY: 16AN XY: 74226
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2022 | The c.488C>T (p.T163I) alteration is located in exon 1 (coding exon 1) of the KRTAP4-8 gene. This alteration results from a C to T substitution at nucleotide position 488, causing the threonine (T) at amino acid position 163 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at